ARDEXXA Trademark

Trademark Overview

On Wednesday, November 30, 2016, a trademark application was filed for ARDEXXA with the United States Patent and Trademark Office. The USPTO has given the ARDEXXA trademark a serial number of 87252180. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2020. This trademark is owned by Portola Pharmaceuticals, Inc.. The ARDEXXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation
ardexxa

General Information

Serial Number87252180
Word MarkARDEXXA
Filing DateWednesday, November 30, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 6, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePortola Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePortola Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, January 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 13, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 3, 2019ASSIGNED TO EXAMINER
Monday, September 30, 2019ASSIGNED TO EXAMINER
Wednesday, May 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2019EXTENSION 4 GRANTED
Monday, May 13, 2019EXTENSION 4 FILED
Monday, May 13, 2019TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2018EXTENSION 3 GRANTED
Monday, December 10, 2018EXTENSION 3 FILED
Monday, December 10, 2018TEAS EXTENSION RECEIVED
Tuesday, June 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 8, 2018EXTENSION 2 GRANTED
Friday, June 8, 2018EXTENSION 2 FILED
Friday, June 8, 2018TEAS EXTENSION RECEIVED
Wednesday, December 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 11, 2017EXTENSION 1 GRANTED
Monday, December 11, 2017EXTENSION 1 FILED
Monday, December 11, 2017TEAS EXTENSION RECEIVED
Tuesday, June 13, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, March 5, 2017ASSIGNED TO EXAMINER
Tuesday, December 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 3, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

ardexxa pharmaceutical preparations hematologic inflammation thrombosis cancers coagulation oncology hematology treatment